Dosimetry-driven alpha emitter selection for radioligand therapy: Is daughter translocation a significant safety concern?
EANM Innovation · 2026-06 · 3 · 100129
DOI: 10.1016/j.eanmi.2026.100129 ↗Kurz gefasst
Fachartikel in der Zeitschrift EANM Innovation, 2026-06. Verfasst von Benjamin Fongenie und 4 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Fongenie, B., Scott, N., Chouin, N., Denis-Bacelar, A. M., & Stevens, D. J. (2026). Dosimetry-driven alpha emitter selection for radioligand therapy: Is daughter translocation a significant safety concern?. EANM Innovation, 3, 100129. https://doi.org/10.1016/j.eanmi.2026.100129
Vancouver
Fongenie B, Scott N, Chouin N, Denis-Bacelar AM, Stevens DJ. Dosimetry-driven alpha emitter selection for radioligand therapy: Is daughter translocation a significant safety concern?. EANM Innovation. 2026;3:100129. doi:10.1016/j.eanmi.2026.100129
BibTeX
@article{Fongenie2026,
author = {Fongenie, Benjamin and Scott, Nathaniel and Chouin, Nicolas and Denis-Bacelar, Ana M. and Stevens, Daniel J.},
title = {Dosimetry-driven alpha emitter selection for radioligand therapy: Is daughter translocation a significant safety concern?},
journal = {EANM Innovation},
year = {2026},
volume = {3},
pages = {100129},
doi = {10.1016/j.eanmi.2026.100129}
}
EUVIMED